[Form 4] ALLISON TRANSMISSION HOLDINGS, INC. Insider Trading Activity
Rhea-AI Filing Summary
Allison Transmission Holdings, Inc. (ALSN) Form 4 shows an insider transaction by Thomas Eifert, listed as VP, Quality Plan & Prog Mgmt and an officer/director. On 08/29/2025 nine dividend equivalent rights that had accrued on previously awarded restricted stock units were converted into nine shares of common stock at a price of $0. After the transaction the reporting person beneficially owned 70 shares of common stock, held directly. The filing was signed by an attorney-in-fact on 09/03/2025. The form indicates a single reporting person and that the dividend equivalents vest proportionately with the related RSUs.
Positive
- Disclosure of vesting event: The Form 4 transparently reports conversion of dividend equivalent rights into shares, meeting Section 16 requirements
- Insider ownership updated: Reporting person now directly owns 70 shares, with 9 shares acquired via dividend equivalents on 08/29/2025
Negative
- None.
Insights
TL;DR: Routine insider acquisition of 9 shares from dividend equivalents; immaterial to company capitalization but relevant for insider holdings transparency.
The Form 4 reports a small, non-cash acquisition of nine shares via dividend equivalent rights tied to RSUs, increasing direct beneficial ownership to 70 shares. This is an administrative vesting event rather than a market purchase or sale. For investors, the disclosure fulfills Section 16 transparency requirements but is not material to Allison Transmission's equity structure given the small share count disclosed.
TL;DR: Compliance filing documents vesting-linked dividend equivalents; indicates proper Section 16 reporting by officer.
The statement clarifies that dividend equivalent rights accrued on RSUs vest proportionately and were converted into common stock on 08/29/2025. The filing was executed by an attorney-in-fact and identifies the reporting persons role. This is a routine disclosure demonstrating adherence to insider reporting obligations without indicating any change in control or compensation policy in the filing itself.